1/28
09:55 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/28
09:55 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/27
05:02 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/26
12:55 pm
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/26
10:02 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/23
09:04 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/23
09:03 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/23
09:03 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/22
10:29 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/22
10:29 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/22
08:45 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
1/22
08:45 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
1/22
05:16 am
vrtx
Vertex upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Vertex upgraded to Outperform from Sector Perform at RBC Capital
1/22
05:16 am
vrtx
Vertex upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Vertex upgraded to Outperform from Sector Perform at RBC Capital
1/12
07:39 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/12
07:39 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/12
07:17 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
1/12
05:53 am
vrtx
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
Low
Report
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
1/12
05:53 am
vrtx
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
Low
Report
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
1/7
08:40 am
vrtx
Rating for VRTX
Low
Report
Rating for VRTX
1/6
08:20 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $548.00 price target on the stock.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $548.00 price target on the stock.
1/6
08:20 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $548.00 price target on the stock.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $548.00 price target on the stock.
1/6
08:15 am
vrtx
Rating for VRTX
Medium
Report
Rating for VRTX
1/6
08:15 am
vrtx
Rating for VRTX
Medium
Report
Rating for VRTX
1/6
07:44 am
vrtx
Vertex Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
Medium
Report
Vertex Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research